181
Views
2
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients

, , , , , , ORCID Icon & show all
Pages 338-341 | Received 02 Jul 2018, Accepted 05 Sep 2018, Published online: 30 Oct 2018

References

  • Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–32.
  • Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol. 2013;303(6–7):324–30.
  • Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42(6):2398–402.
  • Jacob JT, DiazGranados CA. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis. 2013;17(2):e93–100.
  • Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.
  • Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7):653–65.
  • Bradley JS. Which antibiotic for resistant Gram-positives, and why? J Infect. 2014;68 Suppl 1:S63–S75.
  • Eiland LS, English TM, Eiland EH 3rd. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother. 2011;45(5):582–9.
  • Gustinetti G, Cangemi G, Bandettini R, Castagnola E. Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults. J Chemother. 2018;30(2):65–81.
  • Zhanel GG, Lam A, Schweizer F, Thomson K, Walkty A, Rubinstein E, et al. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin. Am J Clin Dermatol. 2008;9(4):245–54.
  • Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. J Antimicrob Chemother. 2007;60(2):300–11.
  • Corey A, So TY. Current clinical trials on the use of ceftaroline in the pediatric population. Clin Drug Investig. 2017;37(7):625–34.
  • The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0, 2018. http://www.eucast.org
  • Strommenger B, Bartels MD, Kurt K, Layer F, Rohde SM, et al. Evolution of methicillin-resistant Staphylococcus aureus towards increasing resistance. J Antimicrob Chemother. 2014;69(3):616–22.
  • Koeth LM, Apfalter P, Becker K, Gesu G, Martínez-Martínez L, Lahiri SD, et al. Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus. Diagn Microbiol Infect Dis. 2016;85(4):452–8.
  • Cantón R, Livermore DM, Morosini MI, Díaz-Regañón J, Rossolini GM, PREMIUM Study Group. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study. J Antimicrob Chemother. 2017;72(2):431–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.